Correlation Between Argyrophilic Nucleolar Organizer Region Staining and Brain Tumor Classification and Grading

REFERENCES

• Rivero, E.R.C.; Aguiar, M.C.F. Análise quantitativa das AgNORs no carcinoma adenóide cístico intra-oral através da técnica de dupla marcação PCNA/AgNOR. J Bras Patol Med Lab 2002, 38(1), 39–44.
   Google Scholar
• Schliephake, H. Prognostic relevance of molecular markers of oral cancer—a review. Int J Oral Maxillofac Surg 2003, 32, 233–245.
   PubMed Web of Science ®Google Scholar
• Bukhari, M.H.; Niazi, S.; Hashmi, I.; Naeem, S.; Abro, A.K.; Tayyab, M.; Chaudhry, N.A. Use of AgNOR index in grading and differential diagnosis of astrocytic lesions of brain. Pak J Med Sci 2007, 23(2), 206–210.
   Web of Science ®Google Scholar
• Trerè, D. AgNOR staining and quantification. Micron 2000, 31, 127–131.
   PubMed Web of Science ®Google Scholar
• Dirven, C.M.F.; Koudstaal, J.; Mooij, J.J.A.; Molenaar, W.M. AgNOR staining may reflect the growth potential of pilocytic astrocytomas. Child's Nerv Syst 1999, 15, 384–388.
   PubMed Web of Science ®Google Scholar
• Masuda, M.; Takano, Y.; Iki, M.; Jinza, S.; Noguchi, S.; Kubota, Y.; Hosaka, M. Predictive value of argyrophilic nucleolar-organizer-region-associated proteins in bladder cancer, using cell-imprint preparations. J Cancer Res Clin Oncol 1997, 123, 1–5.
   PubMed Web of Science ®Google Scholar
• Sirri, V.; Roussel, P.; Hernandez-Verdun, D. The AgNOR proteins: qualitative and quantitative changes during the cell cycle. Micron 2000, 31, 121–126.
   PubMed Web of Science ®Google Scholar
• Janczukowicz, J. The prognostic role of proliferation activity in human CNS tumours: the determination of AgNOR, PCNA and Ki-67 expression. Folia Neuropathol 2003, 41(2), 97–101.
   PubMedGoogle Scholar
• Pich, A.; Chiusa, L.; Margaria, E. Prognostic relevance of AgNORs in tumor pathology. Micron 2000, 31, 133–141.
   PubMed Web of Science ®Google Scholar
• Öfner, D. In situ standardized AgNOR analysis: a simplified method for routine use to determine prognosis and chemotherapy efficiency in colorectal adenocarcinoma. Micron 2000, 31, 161–164.
   PubMed Web of Science ®Google Scholar
• Oshima, C.T.F.; Forones, N.M. AgNOR em câncer gástrico. Arq Gastroenterol 2001, 38(2), 89–93.
   PubMedGoogle Scholar
• Derenzini, M.; Trerè, D.; Pession, A.; Govoni, M.; Sirri, V.; Chieco, P. Nucleolar size indicates the rapidity of cell proliferation in cancer tissues. J Pathol 2000, 191(2), 181–186.
   PubMed Web of Science ®Google Scholar
• Kleihues, P.; Louis, D.N.; Scheithauer, B.W.; Rorke, L.B.; Reifenberger, G.; Burger, P.C.; Cavenee, W.K. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002, 61, 215–225.
   PubMed Web of Science ®Google Scholar
• Louis, D.N.; Ohgaki, H.; Wiestler, O.D.; Cavenee, W.K.; Burger, P.C.; Jouvet, A.; Scheithauer, B.W.; Kleihues, P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007, 114, 97–109.
   PubMed Web of Science ®Google Scholar
• Ford, C.E.; Hamerton, J.L. A colchicine, hypotonic citrate, squash sequence for mammalian chromosomes. Stain Technol 1956, 31(6), 247–251.
   PubMed Web of Science ®Google Scholar
• Howell, W.M.; Black, D.A. Controlled silver staining of nucleolus organizer regions with a protective colloidal developer: a 1 step method. Experimentia 1980, 36, 1014–1015.
   PubMedGoogle Scholar
• Giri, D.D.; Nottingham, J.F.; Lawry, J.; Dundas, S.A.; Underwood, J.C. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry. J Pathol 1989, 157, 307–313.
   PubMed Web of Science ®Google Scholar
• Mamaev, N.N.; Medvedeva, N.V.; Shust, V.F.; Markochev, A.B.; Pasternak, N.D. Nucleoli and AgNOR in Hodkgin's disease. Mol Pathol 1997, 50, 149–152.
   PubMedGoogle Scholar
• Roschoff, J.; Plate, K.H.; Contractor, H.; Kern, S.; Zimmermann, R.; Thomas, C. Evaluation of nucleolus organizer regions (NORs) by automatic image analysis: a contribution to the standardization. J Pathol 1990, 161, 113–118.
   PubMed Web of Science ®Google Scholar
• Zaczek, M.; Dabros, E.; Maciejowski, J.; Szot, W. Identification and assessement of nucleolar organizer regions (NORs): technical problems. Pathol Pol 1994, 45(1), 35–38.
   PubMedGoogle Scholar
• Karasawa, K.; Tada, T.; Kanai, H.; Takagi, T.; Yamada, K. Nucleolar organizing regions in primary intracranial malignant lymphomas. J Neurooncol 1997, 35, 1–6.
   PubMed Web of Science ®Google Scholar
• Lumachi, F.; Ermani, M.; Marino, F.; Poletti, A.; Basso, S.M.M.; Iacobone, M.; Favia, G. Relationship of AgNOR counts and nuclear DNA content to survival in patients with parathyroid carcinoma. Endoc Rel Cancer 2004, 11, 563–569.
   PubMed Web of Science ®Google Scholar
• Egan, M.J.; Crocker, J. Nucleolar organizer regions in cutaneous tumors. J Pathol 1988, 154, 247–253.
   PubMed Web of Science ®Google Scholar
• Derenzini, M.; Ceccarelli, C.; Santini, D.; Taffurelli, M.; Treré, D. The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status. J Clin Pathol 2004, 57, 755–761.
   PubMed Web of Science ®Google Scholar
• Egan, M.; Raafat, F.; Crocker, J.; Williams, D. Comparative study of the degree of differentiation of neuroblastoma and mean numbers of nucleolar organizer regions. J Clin Pathol 1988, 41, 527–531.
   PubMed Web of Science ®Google Scholar
• Remmerbach, T.W.; Weidenbach, H.; Müller, C.; Hemprich, A.; Pomjanski, N.; Buckstegge, B.; Böcking, A. Diagnostic value of nucleolar organizer regions (AgNORs) in brush biopsies of suspicious lesions of the oral cavity. Anal Cell Pathol 2003, 25(3), 139–146.
   PubMedGoogle Scholar
• Hara, H.; Hirayama, H.; Sakai, N.; Yamada, H.; Tanaka, T.; Mori, H. Correlation between nucleolar organizer region staining and Ki-67 immunostaining in human gliomas. Surg Neurol 1990, 33, 320–324.
   PubMed Web of Science ®Google Scholar
• Kajiwara, K.; Nishizaki, T.; Orita, T.; Nakayama, H.; Aoki, H.; Ito, H. Silver colloid staining technique for analysis of glioma malignancy. J Neurosurg 1990, 73, 113–117.
   PubMed Web of Science ®Google Scholar
• Louis, D.N.; Meehan, S.M.; Ferrante, R.J.; Hedley-Whyte, E.T. Use of the silver nucleolar organizer region (AgNOR) technique in the differential diagnosis of central nervous system neoplasia. J Neuropathol Exp Neurol 1992, 51, 150–157.
   PubMed Web of Science ®Google Scholar
• Kudoh, C.H.; Detta, A.; Yeh, J.; Jackowski, A.; Hi-tchock, E.R.; Yoshimizu, N. Rapidly growing benign meningiomas: correlation with clinical features and histological diagnosis. Clinic Neurol Neurosurg 1997, 99(1), 239.
   PubMedGoogle Scholar
• Ahmadi, S.A.; Samadi, N. Evaluation of argyrophilic nucleolar organizer region staining in predicting the behavior of meningiomas. Ann Saudi Med 2006, 26(1), 38–42.
   PubMed Web of Science ®Google Scholar